These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 19514366)

  • 41. Ovarian carcinoma pathology and genetics: recent advances.
    Gilks CB; Prat J
    Hum Pathol; 2009 Sep; 40(9):1213-23. PubMed ID: 19552940
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical value of morphometric and DNA flow cytometric variables as independent predictors of survival in epithelial ovarian carcinoma: a 5-year follow-up study.
    Veerman MM; van der Wurff AA; van de Water M; Kruitwagen RF; Feijen HW; Vos MC
    Int J Gynecol Pathol; 2009 Sep; 28(5):432-41. PubMed ID: 19696612
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CA-125 as a biomarker for malignant transformation of endometriosis.
    Check JH
    Fertil Steril; 2009 May; 91(5):e35; author reply e36. PubMed ID: 19338996
    [No Abstract]   [Full Text] [Related]  

  • 44. Survival from cancer of the ovary in England and Wales up to 2001.
    Kitchener HC
    Br J Cancer; 2008 Sep; 99 Suppl 1(Suppl 1):S73-4. PubMed ID: 18813267
    [No Abstract]   [Full Text] [Related]  

  • 45. High-grade serous carcinoma of the ovary.
    Westfall D; Roma AA; Silva EG
    Ann Diagn Pathol; 2009 Aug; 13(4):285-90. PubMed ID: 19608089
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Correlation of human leukocyte antigen-G (HLA-G) expression and disease progression in epithelial ovarian cancer.
    Jung YW; Kim YT; Kim SW; Kim S; Kim JH; Cho NH; Kim JW
    Reprod Sci; 2009 Nov; 16(11):1103-11. PubMed ID: 19692629
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinicopathological significance of DEK overexpression in serous ovarian tumors.
    Han S; Xuan Y; Liu S; Zhang M; Jin D; Jin R; Lin Z
    Pathol Int; 2009 Jul; 59(7):443-7. PubMed ID: 19563407
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Ovarian sarcoma in childhood].
    Beier U; Kirmse H; Günther L
    Kinderarztl Prax; 1970 Apr; 38(4):172-8. PubMed ID: 5508251
    [No Abstract]   [Full Text] [Related]  

  • 49. [Ca 125 for the diagnosis of ovarian carcinoma].
    Purello D'Ambrosio F; Orlando F; Niosi G; Tigano V; Lombardo G
    Riv Eur Sci Med Farmacol; 1987 Dec; 9(4):401-3. PubMed ID: 3508616
    [No Abstract]   [Full Text] [Related]  

  • 50. Estimating the risk of ovarian cancer.
    Ebell MH
    Am Fam Physician; 2009 Sep; 80(6):632-4. PubMed ID: 19817330
    [No Abstract]   [Full Text] [Related]  

  • 51. Hypercalcemic-type ovarian small cell carcinoma with unique CD34 expression.
    Inadome Y; Shibata T; Suzuki K; Tsugata M; Shimabukuro K; Noguchi M
    Pathol Int; 2009 Oct; 59(10):766-8. PubMed ID: 19788625
    [No Abstract]   [Full Text] [Related]  

  • 52. Prognostic significance of CA-125 in the management of patients with recurrent epithelial ovarian carcinoma selected for secondary cytoreduction.
    Mahner S; Woelber L; Jung S; Eulenburg CZ; Ihnen M; Schwarz J; Sehouli J; Jaenicke F
    Anticancer Res; 2009 Jul; 29(7):2817-21. PubMed ID: 19596967
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Plasma fibrinogen levels and prognosis in patients with ovarian cancer: a multicenter study.
    Polterauer S; Grimm C; Seebacher V; Concin N; Marth C; Tomovski C; Husslein H; Leipold H; Hefler-Frischmuth K; Tempfer C; Reinthaller A; Hefler L
    Oncologist; 2009 Oct; 14(10):979-85. PubMed ID: 19776095
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A pure nongestational ovarian choriocarcinoma in a 10-year-old girl: case report and literature review.
    Kong B; Tian YJ; Zhu WW; Qin YJ
    J Obstet Gynaecol Res; 2009 Jun; 35(3):574-8. PubMed ID: 19527404
    [TBL] [Abstract][Full Text] [Related]  

  • 55. FEZ1/LZTS1 protein expression in ovarian cancer.
    Califano D; Pignata S; Pisano C; Greggi S; Laurelli G; Losito NS; Ottaiano A; Gallipoli A; Pasquinelli R; De Simone V; Cirombella R; Fusco A; Chiappetta G
    J Cell Physiol; 2010 Feb; 222(2):382-6. PubMed ID: 19885841
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of the clinical value of CA 19-9 versus CA 125 for the diagnosis of endometriosis.
    Kurdoglu Z; Gursoy R; Kurdoglu M; Erdem M; Erdem O; Erdem A
    Fertil Steril; 2009 Nov; 92(5):1761-3. PubMed ID: 19631319
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Early diagnosis of ovarian cancer.
    Barber HR
    Compr Ther; 1980 Oct; 6(10):26-33. PubMed ID: 7449361
    [No Abstract]   [Full Text] [Related]  

  • 58. High levels of tumor markers in pleural fluid correlate with poor survival in patients with adenocarcinomatous or squamous malignant effusions.
    Bielsa S; Esquerda A; Salud A; Montes A; Arellano E; Rodríguez-Panadero F; Porcel JM
    Eur J Intern Med; 2009 Jul; 20(4):383-6. PubMed ID: 19524179
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Symptoms of ovarian carcinoma less aspecific than first thought].
    Ansink AC
    Ned Tijdschr Geneeskd; 2009 Jan; 153(1-2):8-9. PubMed ID: 19198204
    [No Abstract]   [Full Text] [Related]  

  • 60. [Diagnosis of ovarian neoplasms at various stages of examination].
    Shuvaeva NI; Popova AA; Antoshechkina ET
    Sov Med; 1978 Aug; (8):145-9. PubMed ID: 705446
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.